Your browser doesn't support javascript.
loading
Imaging features of the evolving patterns of metastatic prostate cancer.
Curcean, A; Curcean, S; Rescigno, P; Dafydd, D Ap; Tree, A; Reid, A; Koh, D-M; Sohaib, A; Tunariu, N; Shur, J.
Afiliación
  • Curcean A; Department of Radiology, The Royal Marsden NHS Foundation Trust, UK; Institute of Cancer Research, Sutton, Surrey, UK.
  • Curcean S; Department of Radiology, The Royal Marsden NHS Foundation Trust, UK.
  • Rescigno P; Department of Radiology, The Royal Marsden NHS Foundation Trust, UK.
  • Dafydd DA; Department of Radiology, The Royal Marsden NHS Foundation Trust, UK.
  • Tree A; Institute of Cancer Research, Sutton, Surrey, UK; Academic Uro-oncology Unit, The Royal Marsden NHS Foundation Trust, UK.
  • Reid A; Institute of Cancer Research, Sutton, Surrey, UK; Academic Uro-oncology Unit, The Royal Marsden NHS Foundation Trust, UK.
  • Koh DM; Department of Radiology, The Royal Marsden NHS Foundation Trust, UK; Institute of Cancer Research, Sutton, Surrey, UK.
  • Sohaib A; Department of Radiology, The Royal Marsden NHS Foundation Trust, UK.
  • Tunariu N; Department of Radiology, The Royal Marsden NHS Foundation Trust, UK; Institute of Cancer Research, Sutton, Surrey, UK.
  • Shur J; Department of Radiology, The Royal Marsden NHS Foundation Trust, UK. Electronic address: Joshua.shur@nhs.net.
Clin Radiol ; 77(2): 88-95, 2022 02.
Article en En | MEDLINE | ID: mdl-34598790
The pattern of metastases in prostate cancer (PC) is evolving. Increased use of imaging, newer imaging techniques with higher sensitivity for disease detection and patients receiving multiple lines of novel therapies with increased life expectancy are likely to be contributory. Awareness of metastatic disease patterns improves early diagnosis, accurate staging, and initiation of appropriate therapy, and can inform prognostic information and anticipate potential disease complications. The aim of this review is to document the spectrum of metastases in PC including emerging and unusual patterns, and to highlight the role of novel imaging including prostate-specific membrane antigen (PSMA)-positron-emission tomography (PET) and whole-body magnetic resonance imaging (WB-MRI) to improve diagnostic and response assessment accuracy.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Imagen por Resonancia Magnética / Tomografía de Emisión de Positrones / Imagen de Cuerpo Entero Tipo de estudio: Screening_studies Límite: Humans / Male Idioma: En Revista: Clin Radiol Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Imagen por Resonancia Magnética / Tomografía de Emisión de Positrones / Imagen de Cuerpo Entero Tipo de estudio: Screening_studies Límite: Humans / Male Idioma: En Revista: Clin Radiol Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido